Will GOCO's Q1 2025 EPS beat forecasts?

**GoHealth's Q1 2025 EPS is unlikely to beat forecasts.** Here's why: 1. **Current Estimates**: The estimated EPS for GoHealth in Q1 2025 is -$0.26. This indicates that analysts are expecting a negative earnings per share for the period. 2. **Historical Performance**: GoHealth has a history of negative earnings reports. For instance, in Q1 2023, the company reported an EPS of -$2.07, which was a significant decrease from the previous year's EPS of -$1.12. This trend suggests that the company has been struggling financially, and it is unlikely to have turned around quickly. 3. **Revenue Expectations**: The estimated revenue for Q1 2025 is $190 million. While this is a substantial figure, it is important to consider the company's historical revenue trends and the fact that they have been declining in recent quarters. 4. **Analyst Sentiments**: The sentiment among analysts is cautious, with no upward revisions to the EPS estimates in the last 3 months. This lack of optimism is a red flag for the possibility of the company beating earnings forecasts. 5. **Previous Misses**: GoHealth has previously missed earnings estimates, with the Q1 2024 earnings report showing a loss of $9.22 million, or -$1.04 per share. This recent performance indicates that the company is still facing significant challenges. In conclusion, given the current estimates, historical performance, analyst sentiments, and the company's recent track record of missing earnings targets, it is doubtful that GoHealth's Q1 2025 EPS will beat forecasts. The company is likely to continue facing financial challenges in the near term.